Novo Nordisk Pharmaceutical Industries H-1B Salaries 2026
10 certified H-1B Labor Condition Applications for full-time roles at Novo Nordisk Pharmaceutical Industries, decided Jul 1, 2025 – Jun 30, 2026. Median offered salary $128,637.
$128,637Median salary
$125,75025th percentile
$133,35375th percentile
10Filings
Novo Nordisk Pharmaceutical Industries H-1B salaries by job title
| Job title | Filings | Median |
|---|---|---|
| QA Area Specialist | 2 | $132,250 |
| Validation Area Specialist III Virginia | 1 | $125,000 |
| Facilities Engineer III Clean Util API | 1 | $128,262 |
| Strategic Business Partner | 1 | $142,863 |
| QA Area Specialist I Sdf | 1 | $80,340 |
| Project Manager II Site Capacity | 1 | $129,012 |
| Associate Manager Quality Control Chemistry | 1 | $128,000 |
| Quality Control Analyst II Ofp | 1 | $82,000 |
| Supply Chain Engineer | 1 | $135,000 |
Top cities
| City | Filings | Median |
|---|---|---|
| Clayton, NC | 5 | $134,457 |
| Durham, NC | 3 | $82,000 |
| Petersburg, VA | 1 | $125,000 |
| Clayon, NC | 1 | $128,262 |
Wage levels
Prevailing-wage level the employer selected (I = entry, IV = fully competent).
Median prevailing wage on these filings: $119,538.
Recent Novo Nordisk Pharmaceutical Industries H-1B filings
Latest 10 of 10 filings by decision date. Salary is the offered wage rate (annualised); "to" shows the top of a range when given.
| Certified | Job title | Salary |
|---|---|---|
| 2026-05-06 | QA Area Specialist IV | $134,457 |
| 2026-05-06 | Project Manager II - Site Capacity | $129,012 |
| 2026-05-06 | QA Area Specialist I - SDF | $80,340 |
| 2026-05-06 | Facilities Engineer III - Clean Util API | $128,262 |
| 2026-05-06 | Strategic Business Partner | $142,863 |
| 2025-12-23 | Validation Area Specialist III - Virginia | $125,000 |
| 2025-11-18 | QA Area Specialist IV | $130,042 |
| 2025-08-28 | Associate Manager, Quality Control Chemistry | $128,000 |
| 2025-07-16 | Quality Control Analyst II OFP | $82,000 |
| 2025-07-08 | Supply Chain Engineer | $135,000 |
Employer names as filed: Novo Nordisk Pharmaceutical Industries, LP. Name variants that differ only in case, punctuation or legal suffix (LLC, Inc., Corp.) are merged. Separate legal entities are listed separately. These are wages offered on certified LCAs, not actual pay.